• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素、孕激素及他莫昔芬单独及与细胞毒性药物联合应用对人卵巢癌的体外作用。

The effects of estrogen, progesterone, and tamoxifen alone and in combination with cytotoxic agents against human ovarian carcinoma in vitro.

作者信息

Geisinger K R, Berens M E, Duckett Y, Morgan T M, Kute T E, Welander C E

机构信息

Department of Pathology, Wake Forest University, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103.

出版信息

Cancer. 1990 Mar 1;65(5):1055-61. doi: 10.1002/1097-0142(19900301)65:5<1055::aid-cncr2820650502>3.0.co;2-9.

DOI:10.1002/1097-0142(19900301)65:5<1055::aid-cncr2820650502>3.0.co;2-9
PMID:2137365
Abstract

The effects of estradiol (E), medroxyprogesterone acetate (MPA), and tamoxifen (TAM) on the growth of a human ovarian carcinoma cell line, BG-1, were evaluated using a tumor clonogenic assay (HTCA). BG-1 contains significant quantities of estrogen and progesterone receptors. Growth inhibition by TAM and growth stimulation by MPA were demonstrated using continuous drug exposure. Estradiol resulted in a marginal increase in colony formation. With each of these three drugs, the greatest response occurred in the larger colonies (generally greater than or equal to 60 microns). Combinations of each of these three steroidal agents with three different cytotoxic drugs were studied in the HTCA. Synergistic activities were produced with TAM combined with either cisplatin or doxorubicin. Additive effects were seen with TAM and cyclophosphamide. Although predominantly additive or synergistic, the effects were variable with MPA and all three cytotoxic agents. Combinations of estradiol with cytotoxic agents were no more active than the cytotoxics alone. These findings indicate a biological rationale for hormonal manipulation as therapy in ovarian cancer.

摘要

使用肿瘤克隆形成试验(HTCA)评估了雌二醇(E)、醋酸甲羟孕酮(MPA)和他莫昔芬(TAM)对人卵巢癌细胞系BG-1生长的影响。BG-1含有大量的雌激素和孕激素受体。通过持续药物暴露证明了TAM的生长抑制作用和MPA的生长刺激作用。雌二醇导致集落形成略有增加。使用这三种药物中的每一种,最大反应都出现在较大的集落中(通常大于或等于60微米)。在HTCA中研究了这三种甾体药物中的每一种与三种不同细胞毒性药物的组合。TAM与顺铂或多柔比星联合产生协同活性。TAM与环磷酰胺联合产生相加作用。虽然主要是相加或协同作用,但MPA与所有三种细胞毒性药物的作用是可变的。雌二醇与细胞毒性药物的组合并不比单独使用细胞毒性药物更具活性。这些发现为激素操纵作为卵巢癌治疗方法提供了生物学依据。

相似文献

1
The effects of estrogen, progesterone, and tamoxifen alone and in combination with cytotoxic agents against human ovarian carcinoma in vitro.雌激素、孕激素及他莫昔芬单独及与细胞毒性药物联合应用对人卵巢癌的体外作用。
Cancer. 1990 Mar 1;65(5):1055-61. doi: 10.1002/1097-0142(19900301)65:5<1055::aid-cncr2820650502>3.0.co;2-9.
2
In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate.他莫昔芬和醋酸甲羟孕酮对子宫内膜癌细胞的体外生长调节作用。
Gynecol Oncol. 1988 Jun;30(2):239-50. doi: 10.1016/0090-8258(88)90030-3.
3
Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay.在软琼脂克隆形成试验中对人乳腺癌进行内分泌治疗检测。
Breast Cancer Res Treat. 1985;6(3):229-35. doi: 10.1007/BF01806773.
4
[Hormone dependence of malignant ovarian tumors--an in vitro model].[恶性卵巢肿瘤的激素依赖性——一种体外模型]
Geburtshilfe Frauenheilkd. 1989 May;49(5):437-41. doi: 10.1055/s-2008-1036398.
5
[Combined chemo- and hormone-therapy in advanced ovarian carcinoma--theoretical, experimental foundations and clinical results].
Wien Klin Wochenschr Suppl. 1990;183:3-29.
6
Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.他莫昔芬-甲羟孕酮序贯疗法对乳腺癌雌激素和孕激素受体含量的影响。
Jpn J Cancer Res. 1989 Mar;80(3):244-8. doi: 10.1111/j.1349-7006.1989.tb02300.x.
7
Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer.他莫昔芬与大剂量醋酸甲羟孕酮在晚期雌激素受体阳性乳腺癌中的周期性应用
Breast Cancer Res Treat. 1990 Nov;17(1):45-50. doi: 10.1007/BF01812683.
8
Alternating sequential endocrine therapy: tamoxifen and medroxyprogesterone acetate versus tamoxifen in postmenopausal advanced breast cancer patients.
Ann Oncol. 1991 Jul;2(7):495-9. doi: 10.1093/oxfordjournals.annonc.a057999.
9
Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.他莫昔芬、苯甲酸雌二醇和醋酸甲羟孕酮对二甲基苯并蒽诱导的大鼠乳腺癌生长的影响。
Chemioterapia. 1985 Jun;4(3):239-42.
10
High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.在适应于无雌激素条件下生长的ZR-75-1人乳腺癌细胞系的一个变体中,孕酮受体浓度较高。
Br J Cancer. 1990 Apr;61(4):504-7. doi: 10.1038/bjc.1990.114.

引用本文的文献

1
Pharmaceutical management of ovarian cancer : current status.卵巢癌的药物治疗:现状
Drugs. 2008;68(6):771-89. doi: 10.2165/00003495-200868060-00004.
2
Estrogen stimulation of ovarian surface epithelial cell proliferation.雌激素对卵巢表面上皮细胞增殖的刺激作用。
In Vitro Cell Dev Biol Anim. 2000 Nov-Dec;36(10):657-66. doi: 10.1290/1071-2690(2000)036<0657:ESOOSE>2.0.CO;2.
3
Synergistic interaction between cisplatin and tamoxifen delays the emergence of cisplatin resistance in head and neck cancer cell lines.
Cancer Chemother Pharmacol. 1995;35(6):511-8. doi: 10.1007/BF00686837.
4
Variable effects of tamoxifen on human hematopoietic progenitor cell growth and sensitivity to doxorubicin.他莫昔芬对人造血祖细胞生长及对多柔比星敏感性的可变效应。
Cancer Chemother Pharmacol. 1994;33(6):509-14. doi: 10.1007/BF00686510.